Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX2GN5
|
||||
| Drug Name |
8-(3-(2-fluoropyridin-3-yl)phenyl)-8-(4-(trifluoromethoxy)phenyl)-4,8-dihydro-3H-imidazo[5,1-c][1,2,4]oxadiazin-6-amine
|
||||
| Synonyms |
CHEMBL567430
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C23H17F4N5O2
|
||||
| Canonical SMILES |
NC1=NC(C2=NOCCN12)(c3ccc(OC(F)(F)F)cc3)c4cccc(c4)c5cccnc5F
|
||||
| InChI |
InChI=1S/C23H17F4N5O2/c24-19-18(5-2-10-29-19)14-3-1-4-16(13-14)22(20-31-33-12-11-32(20)21(28)30-22)15-6-8-17(9-7-15)34-23(25,26)27/h1-10,13H,11-12H2,(H2,28,30)
|
||||
| InChIKey |
SCODXNNXABJQIY-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Renin, renal | Target Info | [1587926] | ||
| Cathepsin D | Target Info | [1587926] | |||
| BioCyc Pathway | Thyroid hormone biosynthesis | ||||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| Pathway Interaction Database | LKB1 signaling events | ||||
| Ceramide signaling pathway | |||||
| Direct p53 effectors | |||||
| Validated nuclear estrogen receptor alpha network | |||||
| PathWhiz Pathway | Angiotensin Metabolism | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.